Rationale and design of lifestyle intervention using mobile technology in patients with high cardiovascular risk: A pragmatic randomized clinical trial.

Mobil teknoloji desteğiyle yüksek riskli kalp hastalıklarında yaşam tarzı değişikliği: Pragmatik randomize klinik çalışma dizaynı.

Journal

Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir
ISSN: 1308-4488
Titre abrégé: Turk Kardiyol Dern Ars
Pays: Turkey
ID NLM: 9426239

Informations de publication

Date de publication:
03 2020
Historique:
entrez: 10 3 2020
pubmed: 10 3 2020
medline: 21 10 2021
Statut: ppublish

Résumé

Cardiovascular disease (CVD) is the leading cause of morbidity and mortality throughout the world and contributes a considerable burden to healthcare costs. Primary prevention strategies, particularly adopting healthy lifestyle habits, have great potential to reduce the risk of CVD. Patient compliance remains the major cause of the failure of primary prevention strategies. Telehealth interventions and gamification through mobile applications can increase adherence and reduce healthcare costs. The primary objective of this study is to compare the effect of lifestyle intervention using mobile technology plus usual care with usual care alone in patients with a high CVD risk.

Identifiants

pubmed: 32147654
doi: 10.5543/tkda.2019.69494
doi:

Types de publication

Clinical Trial Protocol Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

149-157

Auteurs

İlker Tekkesin (İ)

Department of Cardiology, Dr. Siyami Ersek Thoracic and Cardiovascular Surgery Training and Research Center, İstanbul, Turkey.

Göksel Çinier (G)

Department of Cardiology, Kaçkar State Hospital, Rize, Turkey.

Mert Hayıroğlu (M)

Department of Cardiology, Sultan Abdulhamid Han Training and Research Hospital, İstanbul, Turkey.

Yelda Soluk Özdemir (Y)

İstanbul Physical Medication and Rehabilitation Training and Research Hospital, İstanbul, Turkey.

Özlem Yıldırımtürk (Ö)

Department of Cardiology, Dr. Siyami Ersek Thoracic and Cardiovascular Surgery Training and Research Center, İstanbul, Turkey.

Duygu İnan (D)

Department of Cardiology, Dr. Siyami Ersek Thoracic and Cardiovascular Surgery Training and Research Center, İstanbul, Turkey.

Elif Gökçen Vatanoğlu (EG)

Department of Cardiology, Dr. Siyami Ersek Thoracic and Cardiovascular Surgery Training and Research Center, İstanbul, Turkey.

Kemal Emrecan Parsova (KE)

Department of Cardiology, Dr. Siyami Ersek Thoracic and Cardiovascular Surgery Training and Research Center, İstanbul, Turkey.

Gizem Yüksel (G)

Department of Cardiology, Dr. Siyami Ersek Thoracic and Cardiovascular Surgery Training and Research Center, İstanbul, Turkey.

Furkan Durak (F)

Department of Cardiology, Dr. Siyami Ersek Thoracic and Cardiovascular Surgery Training and Research Center, İstanbul, Turkey.

Levent Pay (L)

Department of Cardiology, Dr. Siyami Ersek Thoracic and Cardiovascular Surgery Training and Research Center, İstanbul, Turkey.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH